BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20883777)

  • 1. The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum.
    Cerri S; Piccolini VM; Santin G; Bottone MG; De Pascali SA; Migoni D; Iadarola P; Fanizzi FP; Bernocchi G
    Neurotoxicol Teratol; 2011; 33(2):273-81. PubMed ID: 20883777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental expression of cellular prion protein and apoptotic molecules in the rat cerebellum: effects of platinum compounds.
    Bottone MG; Veronica DB; Piccolini VM; Bottiroli G; De Pascali SA; Fanizzi FP; Bernocchi G
    J Chem Neuroanat; 2012 Dec; 46(1-2):19-29. PubMed ID: 23017299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pt(O,O'-acac)(γ-acac)(DMS)] versus cisplatin: apoptotic effects in B50 neuroblastoma cells.
    Grimaldi M; Santin G; Insolia V; Dal Bo V; Piccolini VM; Veneroni P; Barni S; Verri M; De Pascali SA; Fanizzi FP; Bernocchi G; Bottone MG
    Histochem Cell Biol; 2016 May; 145(5):587-601. PubMed ID: 26748644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects after treatment with platinum compounds, cisplatin and [Pt(O,O'-acac)(γ-acac)(DMS)]: Autophagy activation in rat B50 neuroblastoma cells.
    Grimaldi M; Bo VD; Ferrari B; Roda E; De Luca F; Veneroni P; Barni S; Verri M; De Pascali SA; Fanizzi FP; Bernocchi G; Bottone MG
    Toxicol Appl Pharmacol; 2019 Feb; 364():1-11. PubMed ID: 30529627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebellum neurotransmission during postnatal development: [Pt(O,O'-acac)(γ-acac)(DMS)] vs cisplatin and neurotoxicity.
    Piccolini VM; Esposito A; Dal Bo V; Insolia V; Bottone MG; De Pascali SA; Fanizzi FP; Bernocchi G
    Int J Dev Neurosci; 2015 Feb; 40():24-34. PubMed ID: 25450526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
    Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
    Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum drugs and neurotoxicity: effects on intracellular calcium homeostasis.
    Piccolini VM; Bottone MG; Bottiroli G; De Pascali SA; Fanizzi FP; Bernocchi G
    Cell Biol Toxicol; 2013 Oct; 29(5):339-53. PubMed ID: 23982140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal fibrogenesis and platinum compounds in a rat model: a novel Pt (II) complex vs. cisplatin.
    Fenoglio C; Albicini F; De Pascali SA; Milanesi G; Fumagalli M; Migoni D; Fanizzi FP; Bernocchi G
    Anticancer Res; 2015 Feb; 35(2):739-51. PubMed ID: 25667453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pt(O,O'-acac)(γ-acac)(DMS)]: Alternative Strategies to Overcome Cisplatin-Induced Side Effects and Resistance in T98G Glioma Cells.
    Astesana V; Faris P; Ferrari B; Siciliani S; Lim D; Biggiogera M; De Pascali SA; Fanizzi FP; Roda E; Moccia F; Bottone MG
    Cell Mol Neurobiol; 2021 Apr; 41(3):563-587. PubMed ID: 32430779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
    Kim WK; Kwon YE
    Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of bischolylglycinatechloro-platinum(II) versus cisplatin on liver regeneration after partial hepatectomy.
    Herrera MC; Palomero MF; Macias RI; Serrano MA; Marin JJ
    Anticancer Res; 1998; 18(5A):3555-63. PubMed ID: 9858939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro.
    Kostrhunova H; Vrana O; Suchankova T; Gibson D; Kasparkova J; Brabec V
    Chem Res Toxicol; 2010 Nov; 23(11):1833-42. PubMed ID: 20939593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of a novel platinum compound--cis-dichloro (dimethylsulphoxide) (1-beta-D-rybofuranosyl-1,2,4-triazolo-3-arboxyamide) platinum (II)--"Pt-rib-1"--on cell cycle and apoptosis in ClS91 and B16 mouse melanoma in vitro.
    Drewa T; Olszewska-Słonina D; Woźniak A; Styczyński J; Drewa G; Szłyk E; Lakomska I; Kobe J; Czajkowski R
    Acta Pol Pharm; 2004; 61(1):39-44. PubMed ID: 15259856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The platinum (II) complex [Pt(O,O'-acac)(γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells.
    Muscella A; Calabriso N; Vetrugno C; Fanizzi FP; De Pascali SA; Storelli C; Marsigliante S
    Biochem Pharmacol; 2011 Jan; 81(1):91-103. PubMed ID: 20854797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing central nervous system and vulnerability to platinum compounds.
    Bernocchi G; Bottone MG; Piccolini VM; Dal Bo V; Santin G; De Pascali SA; Migoni D; Fanizzi FP
    Chemother Res Pract; 2011; 2011():315418. PubMed ID: 22312552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.